Argentina Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 513,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "60c53c6d-19fb-423a-a52a-37453b09a52e",
"title": "67.65% of Warren Buffett's Berkshire Hathaway Portfolio is in These 4 Stocks",
"description": "The Oracle of Omaha has a concentrated portfolio allocation strategy.",
"keywords": "",
"snippet": "Bank of America is an advertising partner of The Ascent, a Motley Fool company. Parkev Tatevosian, CFA has positions in Apple. The Motley Fool has positions in ...",
"url": "https://www.fool.com/investing/2023/01/27/6765-of-warren-buffetts-berkshire-hathaway-portfol/",
"image_url": "https://g.foolcdn.com/editorial/images/718224/4-warren-buffett-stocks.jpg",
"language": "en",
"published_at": "2023-01-27T14:02:36.000000Z",
"source": "fool.com",
"relevance_score": null,
"entities": [
{
"symbol": "BRKB.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 117.305725,
"sentiment_score": 0,
"highlights": [
{
"highlight": "67.65% of Warren Buffett's <em>Berkshire</em> <em>Hathaway</em> Portfolio is in These 4 Stocks",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "BRKBD.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 117.30594,
"sentiment_score": 0,
"highlights": [
{
"highlight": "67.65% of Warren Buffett's <em>Berkshire</em> <em>Hathaway</em> Portfolio is in These 4 Stocks",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "BRKBB.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 117.30594,
"sentiment_score": 0,
"highlights": [
{
"highlight": "67.65% of Warren Buffett's <em>Berkshire</em> <em>Hathaway</em> Portfolio is in These 4 Stocks",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "66fc6d6c-6868-4753-bf89-557441e86802",
"title": "67.65% of Warren Buffett's Berkshire Hathaway Portfolio is in These 4 Stocks",
"description": "Apple (NASDAQ: AAPL) and Coca-Cola (NYSE: KO) are among the portfolio's top holdings. This video will highlight the stocks and determine what Warren Buffett sees in these four companies. *Stock prices used were the afternoon prices of Jan.",
"keywords": "",
"snippet": "Apple (NASDAQ: AAPL) and Coca-Cola (NYSE: KO) are among the portfolio's top holdings. This video will highlight the stocks and determine what Warren Buffett see...",
"url": "https://finance.yahoo.com/m/2f0f5c9b-bead-3d34-9f37-e65a6a339439/67.65%25-of-warren-buffett%27s.html?.tsrc=rss",
"image_url": "https://s.yimg.com/ny/api/res/1.2/dfcBF4VKWho2OiV.15EHmg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/motleyfool.com/c4a612567496742b6468fa81bbcf7201",
"language": "en",
"published_at": "2023-01-27T14:02:36.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "BRKB.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 117.305725,
"sentiment_score": 0,
"highlights": [
{
"highlight": "67.65% of Warren Buffett's <em>Berkshire</em> <em>Hathaway</em> Portfolio is in These 4 Stocks",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "BRKBD.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 117.30594,
"sentiment_score": 0,
"highlights": [
{
"highlight": "67.65% of Warren Buffett's <em>Berkshire</em> <em>Hathaway</em> Portfolio is in These 4 Stocks",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "BRKBB.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 117.30594,
"sentiment_score": 0,
"highlights": [
{
"highlight": "67.65% of Warren Buffett's <em>Berkshire</em> <em>Hathaway</em> Portfolio is in These 4 Stocks",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "dbf54f1e-b8aa-4dff-be76-cfae446cb662",
"title": "Automotive Endpoint Authentication Market to Hit USD 1.93 Billion by 2028, at a CAGR of 13.84% from 2022-2028 due to Increasing Efforts to Limit Vehicle Theft",
"description": "The latest research report on the automotive endpoint authentication market provides in-depth quantitative and qualitative analysis in terms of market...",
"keywords": "SkyQuest Technology Consulting Pvt. Ltd., Automotive Endpoint, Endpoint Authentication",
"snippet": "Westford, USA, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Europe to attract significant revenue share in the global automotive endpoint authentication market . An increa...",
"url": "https://www.globenewswire.com/news-release/2023/01/27/2596955/0/en/Automotive-Endpoint-Authentication-Market-to-Hit-USD-1-93-Billion-by-2028-at-a-CAGR-of-13-84-from-2022-2028-due-to-Increasing-Efforts-to-Limit-Vehicle-Theft.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/c673c6fa-f0e7-47bf-8490-fe528c593820?size=1",
"language": "en",
"published_at": "2023-01-27T14:02:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "GRMN.BA",
"name": "Garmin Ltd.",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Technology",
"match_score": 17.388,
"sentiment_score": -0.2808,
"highlights": [
{
"highlight": "<em>Garmin</em> <em>Ltd</em>.\n\nContinental AG\n\nBrembo S.p.A.\n\nSynaptics Incorporated\n\nMotherson Group\n\nSamsung Electronics Co. Ltd.\n\nFujitsu Ltd.\n\nFitbit Inc.\n\nOIA Global\n\nRenesas Electronics Corporation\n\nSymantec Corporation\n\nHID Global Corporation\n\nK7 Computing Pvt. Ltd.",
"sentiment": -0.2808,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "6b772b19-96cd-4359-9d45-c39f0c9af71e",
"title": "Monoclonal Antibody Discovery and Analysis market is projected to grow at a CAGR of 9.0% by 2032: Visiongain Reports Ltd",
"description": "Visiongain has published a new report entitled Monoclonal Antibody Discovery and Analysis 2022-2032. It includes profiles of Monoclonal Antibody Discovery...",
"keywords": "Visiongain Reports Ltd, Monoclonal Antibody, Drug Discovery Development, Next Generation Technologies",
"snippet": "Visiongain has published a new report entitled Monoclonal Antibody Discovery and Analysis 2022-2032. It includes profiles of Monoclonal Antibody Discovery and A...",
"url": "https://www.globenewswire.com/news-release/2023/01/27/2596951/0/en/Monoclonal-Antibody-Discovery-and-Analysis-market-is-projected-to-grow-at-a-CAGR-of-9-0-by-2032-Visiongain-Reports-Ltd.html",
"image_url": "https://ml-eu.globenewswire.com/Resource/Download/6bdb779b-409b-453a-a1ac-5548f5b2a98e?size=1",
"language": "en",
"published_at": "2023-01-27T14:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "BMY.BA",
"name": "Bristol-Myers Squibb Company",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 25.12838,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., Amneal Pharmaceutical LLC, AstraZeneca, Bayer AG, BIOGEN, <em>Bristol</em>- <em>Myers</em> <em>Squibb</em> <em>company</em>, Eisai Co. Ltd, Eli Lilly and Company, F.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DJNJ2.BA",
"name": "Johnson & Johnson",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.341129,
"sentiment_score": -0.4215,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, <em>Johnson</em> & <em>Johnson</em> Ltd., Lupin Limited, Viatris Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, .",
"sentiment": -0.4215,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DJNJ3.BA",
"name": "Johnson & Johnson",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.341129,
"sentiment_score": -0.4215,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, <em>Johnson</em> & <em>Johnson</em> Ltd., Lupin Limited, Viatris Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, .",
"sentiment": -0.4215,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFED.BA",
"name": "PFIZER INC",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 8.456402,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Novartis AG, <em>Pfizer</em> <em>Inc</em>., Regeneron Pharmaceuticals Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, . These major players operating in this market have adopted various strategies comprising M&A, investment in R&D, collaborations, partnerships, regional business expansion, and new product launch.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AMGN.BA",
"name": "Amgen Inc.",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 14.191601,
"sentiment_score": -0.20095,
"highlights": [
{
"highlight": "., <em>Amgen</em> <em>Inc</em>., Amneal Pharmaceutical LLC, AstraZeneca, Bayer AG, BIOGEN, Bristol- Myers Squibb company, Eisai Co. Ltd, Eli Lilly and Company, F.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Recent Developments\n\nIn January 2022, <em>Amgen</em> and Arrakis Medicines partnered in research with the aim of identifying and developing RNA degrader therapies against a range of hard-to-treat targets in a number of therapeutic areas.",
"sentiment": -0.4019,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.BA",
"name": "Eli Lilly and Company",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 18.005447,
"sentiment_score": -0.4215,
"highlights": [
{
"highlight": "Ltd, <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em>, F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson Ltd., Lupin Limited, Viatris Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, .",
"sentiment": -0.4215,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVSD.BA",
"name": "NOVARTIS AG",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 11.491248,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Novartis</em> <em>AG</em>, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, . These major players operating in this market have adopted various strategies comprising M&A, investment in R&D, collaborations, partnerships, regional business expansion, and new product launch.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ABBV.BA",
"name": "AbbVie Inc.",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 11.32825,
"sentiment_score": 0.1779,
"highlights": [
{
"highlight": "Competitive Landscape\n\nThe major players operating in the monoclonal antibody discovery and analysis market are <em>AbbVie</em> <em>Inc</em>., Amgen Inc., Amneal Pharmaceutical LLC, AstraZeneca, Bayer AG, BIOGEN, Bristol- Myers Squibb company, Eisai Co. Ltd, Eli Lilly and Company, F.",
"sentiment": 0.1779,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BAYN.BA",
"name": "BAYER AG",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 10.186593,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., Amneal Pharmaceutical LLC, AstraZeneca, <em>Bayer</em> <em>AG</em>, BIOGEN, Bristol- Myers Squibb company, Eisai Co. Ltd, Eli Lilly and Company, F.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ABBVD.BA",
"name": "ABBVIE INC",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 11.32825,
"sentiment_score": 0.1779,
"highlights": [
{
"highlight": "Competitive Landscape\n\nThe major players operating in the monoclonal antibody discovery and analysis market are <em>AbbVie</em> <em>Inc</em>., Amgen Inc., Amneal Pharmaceutical LLC, AstraZeneca, Bayer AG, BIOGEN, Bristol- Myers Squibb company, Eisai Co. Ltd, Eli Lilly and Company, F.",
"sentiment": 0.1779,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "0ee7aed2-7c85-4831-9c08-2dc9abb02541",
"title": "Complicated Urinary Tract Infections Treatment Market Size is projected to reach USD 16.1 billion by 2033, trailing a CAGR of 5.76% Says Future Market Insights, Inc.",
"description": "Adoption of New Assays and Launch of Combination Drugs Will Propel Growth of Complicated Urinary Tract Infections Treatment Market. North America to be one...",
"keywords": "Future Market Insights Global and Consulting Pvt. Ltd., Urinary Tract Infections, Urinary Infections treatment, UTI Treatment Market",
"snippet": "NEWARK, Del, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The global Complicated Urinary Tract Infections treatment market size is expected to surpass an impressive valuat...",
"url": "https://www.globenewswire.com/news-release/2023/01/27/2596763/0/en/Complicated-Urinary-Tract-Infections-Treatment-Market-Size-is-projected-to-reach-USD-16-1-billion-by-2033-trailing-a-CAGR-of-5-76-Says-Future-Market-Insights-Inc.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/915d2f9c-7dc6-40c7-995c-2ba168208baa?size=1",
"language": "en",
"published_at": "2023-01-27T11:30:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "BMY.MX",
"name": "Bristol-Myers Squibb Company",
"exchange": "BMV",
"exchange_long": "Mexican Stock Exchange",
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 30.21268,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, Pfizer, Inc, GlaxoSmithKline plc, <em>Bristol</em>-<em>Myers</em> <em>Squibb</em> <em>Company</em>, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.MX",
"name": "Pfizer Inc.",
"exchange": "BMV",
"exchange_long": "Mexican Stock Exchange",
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.026414,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, <em>Pfizer</em>, <em>Inc</em>, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GLAXF",
"name": "GlaxoSmithKline plc",
"exchange": "OTC",
"exchange_long": "Over-the-counter Markets",
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 14.724999,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, Pfizer, Inc, <em>GlaxoSmithKline</em> <em>plc</em>, Bristol-Myers Squibb Company, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GSK.L",
"name": "GlaxoSmithKline plc",
"exchange": "LSE",
"exchange_long": "London Stock Exchange",
"country": "gb",
"type": "equity",
"industry": "Healthcare",
"match_score": 14.724812,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, Pfizer, Inc, <em>GlaxoSmithKline</em> <em>plc</em>, Bristol-Myers Squibb Company, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.ST",
"name": "Pfizer Inc.",
"exchange": "OMXS",
"exchange_long": "Nasdaq Stockholm",
"country": "se",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.026947,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, <em>Pfizer</em>, <em>Inc</em>, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BMYB34.SA",
"name": "Bristol-Myers Squibb Company",
"exchange": "BVMF",
"exchange_long": "The B3 S.A. - Brasil, Bolsa, Balcão",
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 30.21342,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, Pfizer, Inc, GlaxoSmithKline plc, <em>Bristol</em>-<em>Myers</em> <em>Squibb</em> <em>Company</em>, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SPRO",
"name": "Spero Therapeutics, Inc.",
"exchange": "NASDAQ",
"exchange_long": "NASDAQ Stock Exchange",
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 23.435373,
"sentiment_score": 0.23835,
"highlights": [
{
"highlight": "The major players in the market are: <em>Spero</em> <em>Therapeutics</em>, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, Pfizer, Inc, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "In October 2021, <em>Spero</em> <em>Therapeutics</em> <em>Inc</em>. submitted a new drug application (NDA) to the US Food and Drug Administration (FDA), seeking approval for tebipenem HBr tablets for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis, caused by susceptible microorganisms.",
"sentiment": 0.4767,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BMY",
"name": "Bristol-Myers Squibb Company",
"exchange": "NYSE",
"exchange_long": "New York Stock Exchange",
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 30.21252,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, Pfizer, Inc, GlaxoSmithKline plc, <em>Bristol</em>-<em>Myers</em> <em>Squibb</em> <em>Company</em>, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GSK",
"name": "GlaxoSmithKline plc",
"exchange": "NYSE",
"exchange_long": "New York Stock Exchange",
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 14.724225,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, Pfizer, Inc, <em>GlaxoSmithKline</em> <em>plc</em>, Bristol-Myers Squibb Company, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": "NYSE",
"exchange_long": "New York Stock Exchange",
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.027082,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, <em>Pfizer</em>, <em>Inc</em>, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE-WI",
"name": "Pfizer, Inc.",
"exchange": "NYSE",
"exchange_long": "New York Stock Exchange",
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 10.027082,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, <em>Pfizer</em>, <em>Inc</em>, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BMY.BA",
"name": "Bristol-Myers Squibb Company",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 30.210987,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, Pfizer, Inc, GlaxoSmithKline plc, <em>Bristol</em>-<em>Myers</em> <em>Squibb</em> <em>Company</em>, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFED.BA",
"name": "PFIZER INC",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 10.027081,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, <em>Pfizer</em>, <em>Inc</em>, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BAYN.BA",
"name": "BAYER AG",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 12.121731,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, <em>Bayer</em> <em>AG</em>, Pfizer, Inc, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 10.026982,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, <em>Pfizer</em>, <em>Inc</em>, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 10.02698,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The major players in the market are: Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Nabriva Therapeutics AG, MerLion Pharmaceuticals, Allergan, Bayer AG, <em>Pfizer</em>, <em>Inc</em>, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Janssen Global Services, LLC\n\nSome recent developments in this industry are:\n\nIn November 2020, Allergan",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "85b2c7b9-a14e-4a06-9074-6f9a906c7998",
"title": "Qualtrics International: Interesting Catalyst Create Enthusiasm",
"description": "Qualtrics International is growing well and results are improving. Read this article to know what makes me neutral on XM stock.",
"keywords": "",
"snippet": "courtneyk\n\nBuying into rapidly growing technology companies can be a great way to generate strong returns. It can also be a great way to lose a lot of money. Bu...",
"url": "https://seekingalpha.com/article/4572956-qualtrics-international-great-growth-interesting-catalyst-cement-investor-enthusiasm",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1368098469/image_1368098469.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2023-01-27T13:53:00.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SAP.BA",
"name": "SAP SE",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Technology",
"match_score": 9.849284,
"sentiment_score": 0,
"highlights": [
{
"highlight": "On January 26th, <em>SAP</em> <em>SE</em> (SAP) announced its latest quarterly results. During that time, the company also said that it was exploring a sale of its 71% stake in Qualtrics International. This is in addition to its decision to let go of around 3,000 employees with the aim of saving hundreds of millions of dollars annually.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SAPD.BA",
"name": "SAP SE",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 9.849293,
"sentiment_score": 0,
"highlights": [
{
"highlight": "On January 26th, <em>SAP</em> <em>SE</em> (SAP) announced its latest quarterly results. During that time, the company also said that it was exploring a sale of its 71% stake in Qualtrics International. This is in addition to its decision to let go of around 3,000 employees with the aim of saving hundreds of millions of dollars annually.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "8b42e2b7-c98a-4c64-b2a5-387a676fda4a",
"title": "Budget 2023: Govt likely to avoid populist measures; tax tweaks possible",
"description": "FM Sitharaman is unlikely to tinker much with tax rates, yet will also steer clear of populist measures, according to economists surveyed",
"keywords": "budget 2023, Nirmala Sitharaman, Narendra Modi, union budget, indian economy, gdp, middle class, household income, gross domestic product",
"snippet": "India’s government will look to maintain its pace of spending to bolster growth as it leans on asset sales while shunning subsidies to shrink the deficit, acc...",
"url": "https://www.business-standard.com/budget/article/budget-2023-govt-likely-to-avoid-populist-measures-tax-tweaks-possible-123012701039_1.html",
"image_url": "https://bsmedia.business-standard.com/_media/bs/img/article/2022-09/01/full/1662027283-2439.jpg",
"language": "en",
"published_at": "2023-01-27T13:35:33.000000Z",
"source": "business-standard.com",
"relevance_score": null,
"entities": [
{
"symbol": "BCS.BA",
"name": "Barclays PLC",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Financial Services",
"match_score": 17.808231,
"sentiment_score": 0.6808,
"highlights": [
{
"highlight": "“We expect the production-linked incentives to continue,” said Rahul Bajoria, economist at <em>Barclays</em> <em>Plc</em>. “The government may also tweak inverted-duty structure wherever they can to encourage domestic manufacturing.”",
"sentiment": 0.6808,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "19687728-e98f-4c18-8d2f-95f476cf1637",
"title": "Markel Stock: A Buffett-Like Wealth Compounder (NYSE:MKL)",
"description": "Markel is a well-run insurance company with a conservative underwriting philosophy and strong investment returns. See why MKL stock is a hold.",
"keywords": "",
"snippet": "JuSun\n\nThere are few stocks that an investor can tuck away and not have to worry about too much. Berkshire Hathaway (BRK.A)(BRK.B) may be one of them. A problem...",
"url": "https://seekingalpha.com/article/4572862-markel-stock-warren-buffett-like-wealth-compounder",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1248262649/image_1248262649.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2023-01-27T13:30:00.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "BRKB.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 41.247505,
"sentiment_score": 0.25445,
"highlights": [
{
"highlight": "<em>Berkshire</em> <em>Hathaway</em> (BRK.A)(BRK.B) may be one of them. A problem for <em>Berkshire</em> <em>Hathaway</em>, however, is that its large size makes it difficult to source enough attractive deals to move the needle.\n\nThis brings me to the comparatively smaller Markel Corporation (NYSE:MKL) which operates with a similar business model.",
"sentiment": -0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Investor Takeaway\n\nMarkel Corporation is a unique insurance company in that it operates like a mini-<em>Berkshire</em> <em>Hathaway</em>. The company has managed to outperform the market over the long run thanks to its conservative underwriting philosophy and strong investment returns.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BRKBD.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 41.24755,
"sentiment_score": 0.25445,
"highlights": [
{
"highlight": "<em>Berkshire</em> <em>Hathaway</em> (BRK.A)(BRK.B) may be one of them. A problem for <em>Berkshire</em> <em>Hathaway</em>, however, is that its large size makes it difficult to source enough attractive deals to move the needle.\n\nThis brings me to the comparatively smaller Markel Corporation (NYSE:MKL) which operates with a similar business model.",
"sentiment": -0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Investor Takeaway\n\nMarkel Corporation is a unique insurance company in that it operates like a mini-<em>Berkshire</em> <em>Hathaway</em>. The company has managed to outperform the market over the long run thanks to its conservative underwriting philosophy and strong investment returns.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BRKBB.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 41.24755,
"sentiment_score": 0.25445,
"highlights": [
{
"highlight": "<em>Berkshire</em> <em>Hathaway</em> (BRK.A)(BRK.B) may be one of them. A problem for <em>Berkshire</em> <em>Hathaway</em>, however, is that its large size makes it difficult to source enough attractive deals to move the needle.\n\nThis brings me to the comparatively smaller Markel Corporation (NYSE:MKL) which operates with a similar business model.",
"sentiment": -0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Investor Takeaway\n\nMarkel Corporation is a unique insurance company in that it operates like a mini-<em>Berkshire</em> <em>Hathaway</em>. The company has managed to outperform the market over the long run thanks to its conservative underwriting philosophy and strong investment returns.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "cec57e29-db1c-4e65-9e8d-ea5332bd9074",
"title": "Goldman Sachs finds criticism from The Economist",
"description": "'The firm is not yet in serious trouble, but it is trapped by its own mythology,' the Economist writes",
"keywords": "article_normal, Banking, Financial Investment Services, Investment Banking, Security Brokering/Dealing, Banking/Credit, Financial Services, Investing/Securities, Financial Performance, Corporate/Industrial News, Content Types, Factiva Filters, C&E Industry News Filter, Morgan Stanley, MS, Blackstone Inc., BX, Amazon.com Inc., AMZN, PayPal Holdings Inc., PYPL, BlackRock Inc., BLK, Goldman Sachs Group Inc., GS, JPMorgan Chase & Co., JPM, SPX, S&P 500 Index, financial performance, corporate, industrial news, content types, factiva filters, c&e industry news filter, banking, financial investment services, investment banking, security brokering, dealing, credit, financial services, investing, securities",
"snippet": "Goldman Sachs criticism is now on the front page of a major business publication.\n\nThis week’s Economist magazine featured a melting blue Goldman Sachs Group ...",
"url": "https://www.marketwatch.com/story/goldman-sachs-finds-criticism-from-the-economist-11674825798",
"image_url": "https://images.mktw.net/im-711646/social",
"language": "en",
"published_at": "2023-01-27T13:23:00.000000Z",
"source": "marketwatch.com",
"relevance_score": null,
"entities": [
{
"symbol": "JPMC.BA",
"name": "JPMORGAN CHASE &CO",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 33.182102,
"sentiment_score": -0.25,
"highlights": [
{
"highlight": "The Economist’s article entitled “The Humbling of Goldman Sachs” depicted the bank’s challenge of reinventing itself after being outshined in 2022 by <em>JPMorgan</em> <em>Chase</em> & <em>Co</em>. JPM, +0.62% and Morgan Stanley MS, +0.90% — and trapped within the confines of Wall Street’s traditional investment banking businesses.",
"sentiment": -0.25,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "b71ba1d1-3e0f-4216-8143-a9c7154e1b98",
"title": "Market closing in on a record despite negative news",
"description": "Australia’s share market has continued to push through a raft of negative news to bring the ASX 200 index within reach of an all-time record high.",
"keywords": "",
"snippet": "Australia’s share market has continued to push through a raft of negative news to bring the ASX 200 index within reach of an all-time record high.\n\nIn Friday ...",
"url": "https://smallcaps.com.au/market-closing-in-on-record-despite-negative-news-weekly-review/",
"image_url": "https://smallcaps.com.au/wp-content/uploads/2023/01/Market-negative-news-Australia-January-2023.jpg",
"language": "en",
"published_at": "2023-01-27T13:19:51.000000Z",
"source": "smallcaps.com.au",
"relevance_score": null,
"entities": [
{
"symbol": "RIOD.BA",
"name": "RIO TINTO",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 14.123158,
"sentiment_score": 0.7845,
"highlights": [
{
"highlight": "Elsewhere in the mining sector though, trading remained firm with BHP (ASX: BHP) shares up 0.6% and <em>Rio</em> <em>Tinto</em> (ASX: RIO) shares 0.4% higher on the back of continuing optimism about iron ore and other commodities.\n\nSmall cap stock action\n\nThe Small Ords index rose 0.88% this week to close on 3012.0 points.",
"sentiment": 0.7845,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "02c977ab-45bf-41bc-81ad-05c64f8d9b13",
"title": "Apple’s iPhone Dominated China Last Quarter Despite Disruptions",
"description": "(Bloomberg) -- Apple Inc. won its biggest quarterly market share in China, outrunning Covid disruptions and a global economic slowdown.Most Read from BloombergHindenburg vs Adani: The Short Seller Taking On Asia’s Richest PersonWe Asked ChatGPT to Make a Market-Beating ETF. Here’s What HappenedNYSE Mayhem Traced to a Staffer Who Left a Backup System RunningAdani Rout Crosses $50 Billion as Stocks Plunge by Daily LimitsThe Cupertino, California company accounted for nearly 24% of China’s smartpho",
"keywords": "",
"snippet": "(Bloomberg) -- Apple Inc. won its biggest quarterly market share in China, outrunning Covid disruptions and a global economic slowdown.\n\nMost Read from Bloomber...",
"url": "https://finance.yahoo.com/news/apple-iphone-dominated-china-last-090048062.html?.tsrc=rss",
"image_url": "https://s.yimg.com/ny/api/res/1.2/eXnQ2NkyLXH_q77hMDalhQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03MDA-/https://media.zenfs.com/en/bloomberg_technology_68/b25c8ee14a0738e59f707b023e094892",
"language": "en",
"published_at": "2023-01-27T09:00:48.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL.BA",
"name": "Apple Inc.",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Technology",
"match_score": 16.990978,
"sentiment_score": -0.0382,
"highlights": [
{
"highlight": "(Bloomberg) -- <em>Apple</em> <em>Inc</em>. won its biggest quarterly market share in China, outrunning Covid disruptions and a global economic slowdown.\n\nMost Read from Bloomberg\n\nThe Cupertino, California company accounted for nearly 24% of China’s smartphone sales in the last three months of 2022, according to Counterpoint Research data.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> saw lower demand for its latest generation of iPhones than it had projected earlier this year. Its iPhone Pro models remained in high demand, but deliveries were challenged by coronavirus lockdowns and worker protests at its Zhengzhou plant in China. The company reports earnings on Feb. 2.",
"sentiment": -0.6187,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AAPLD.BA",
"name": "APPLE INC",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 16.990978,
"sentiment_score": -0.0382,
"highlights": [
{
"highlight": "(Bloomberg) -- <em>Apple</em> <em>Inc</em>. won its biggest quarterly market share in China, outrunning Covid disruptions and a global economic slowdown.\n\nMost Read from Bloomberg\n\nThe Cupertino, California company accounted for nearly 24% of China’s smartphone sales in the last three months of 2022, according to Counterpoint Research data.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> saw lower demand for its latest generation of iPhones than it had projected earlier this year. Its iPhone Pro models remained in high demand, but deliveries were challenged by coronavirus lockdowns and worker protests at its Zhengzhou plant in China. The company reports earnings on Feb. 2.",
"sentiment": -0.6187,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AAPLC.BA",
"name": "APPLE INC",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 16.990978,
"sentiment_score": -0.0382,
"highlights": [
{
"highlight": "(Bloomberg) -- <em>Apple</em> <em>Inc</em>. won its biggest quarterly market share in China, outrunning Covid disruptions and a global economic slowdown.\n\nMost Read from Bloomberg\n\nThe Cupertino, California company accounted for nearly 24% of China’s smartphone sales in the last three months of 2022, according to Counterpoint Research data.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> saw lower demand for its latest generation of iPhones than it had projected earlier this year. Its iPhone Pro models remained in high demand, but deliveries were challenged by coronavirus lockdowns and worker protests at its Zhengzhou plant in China. The company reports earnings on Feb. 2.",
"sentiment": -0.6187,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AAPLCL.SN",
"name": "APPLE INC",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 16.990894,
"sentiment_score": -0.0382,
"highlights": [
{
"highlight": "(Bloomberg) -- <em>Apple</em> <em>Inc</em>. won its biggest quarterly market share in China, outrunning Covid disruptions and a global economic slowdown.\n\nMost Read from Bloomberg\n\nThe Cupertino, California company accounted for nearly 24% of China’s smartphone sales in the last three months of 2022, according to Counterpoint Research data.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> saw lower demand for its latest generation of iPhones than it had projected earlier this year. Its iPhone Pro models remained in high demand, but deliveries were challenged by coronavirus lockdowns and worker protests at its Zhengzhou plant in China. The company reports earnings on Feb. 2.",
"sentiment": -0.6187,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AAPL.SN",
"name": "Apple Inc.",
"exchange": "SSE",
"exchange_long": "Santiago Stock Exchange",
"country": "cl",
"type": "equity",
"industry": "Technology",
"match_score": 16.990894,
"sentiment_score": -0.0382,
"highlights": [
{
"highlight": "(Bloomberg) -- <em>Apple</em> <em>Inc</em>. won its biggest quarterly market share in China, outrunning Covid disruptions and a global economic slowdown.\n\nMost Read from Bloomberg\n\nThe Cupertino, California company accounted for nearly 24% of China’s smartphone sales in the last three months of 2022, according to Counterpoint Research data.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> saw lower demand for its latest generation of iPhones than it had projected earlier this year. Its iPhone Pro models remained in high demand, but deliveries were challenged by coronavirus lockdowns and worker protests at its Zhengzhou plant in China. The company reports earnings on Feb. 2.",
"sentiment": -0.6187,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AAPL",
"name": "Apple Inc.",
"exchange": "NASDAQ",
"exchange_long": "NASDAQ Stock Exchange",
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 16.99094,
"sentiment_score": -0.0382,
"highlights": [
{
"highlight": "(Bloomberg) -- <em>Apple</em> <em>Inc</em>. won its biggest quarterly market share in China, outrunning Covid disruptions and a global economic slowdown.\n\nMost Read from Bloomberg\n\nThe Cupertino, California company accounted for nearly 24% of China’s smartphone sales in the last three months of 2022, according to Counterpoint Research data.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> saw lower demand for its latest generation of iPhones than it had projected earlier this year. Its iPhone Pro models remained in high demand, but deliveries were challenged by coronavirus lockdowns and worker protests at its Zhengzhou plant in China. The company reports earnings on Feb. 2.",
"sentiment": -0.6187,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AAPL.NE",
"name": "Apple Inc.",
"exchange": "NEO",
"exchange_long": "NEO Exchange",
"country": "ca",
"type": "equity",
"industry": "Technology",
"match_score": 16.99095,
"sentiment_score": -0.0382,
"highlights": [
{
"highlight": "(Bloomberg) -- <em>Apple</em> <em>Inc</em>. won its biggest quarterly market share in China, outrunning Covid disruptions and a global economic slowdown.\n\nMost Read from Bloomberg\n\nThe Cupertino, California company accounted for nearly 24% of China’s smartphone sales in the last three months of 2022, according to Counterpoint Research data.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> saw lower demand for its latest generation of iPhones than it had projected earlier this year. Its iPhone Pro models remained in high demand, but deliveries were challenged by coronavirus lockdowns and worker protests at its Zhengzhou plant in China. The company reports earnings on Feb. 2.",
"sentiment": -0.6187,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "APC.DE",
"name": "Apple Inc.",
"exchange": "XETRA",
"exchange_long": "Deutsche Börse Xetra",
"country": "de",
"type": "equity",
"industry": "Technology",
"match_score": 16.991293,
"sentiment_score": -0.0382,
"highlights": [
{
"highlight": "(Bloomberg) -- <em>Apple</em> <em>Inc</em>. won its biggest quarterly market share in China, outrunning Covid disruptions and a global economic slowdown.\n\nMost Read from Bloomberg\n\nThe Cupertino, California company accounted for nearly 24% of China’s smartphone sales in the last three months of 2022, according to Counterpoint Research data.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> saw lower demand for its latest generation of iPhones than it had projected earlier this year. Its iPhone Pro models remained in high demand, but deliveries were challenged by coronavirus lockdowns and worker protests at its Zhengzhou plant in China. The company reports earnings on Feb. 2.",
"sentiment": -0.6187,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AAPL.MX",
"name": "Apple Inc.",
"exchange": "BMV",
"exchange_long": "Mexican Stock Exchange",
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 16.991331,
"sentiment_score": -0.0382,
"highlights": [
{
"highlight": "(Bloomberg) -- <em>Apple</em> <em>Inc</em>. won its biggest quarterly market share in China, outrunning Covid disruptions and a global economic slowdown.\n\nMost Read from Bloomberg\n\nThe Cupertino, California company accounted for nearly 24% of China’s smartphone sales in the last three months of 2022, according to Counterpoint Research data.",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> saw lower demand for its latest generation of iPhones than it had projected earlier this year. Its iPhone Pro models remained in high demand, but deliveries were challenged by coronavirus lockdowns and worker protests at its Zhengzhou plant in China. The company reports earnings on Feb. 2.",
"sentiment": -0.6187,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "6345a1ab-937d-4fce-98ba-e67a64034973",
"title": "Enterprise Software Market Report Growth, Trends, COVID-19 Impact, and Forecast 2019–2028.",
"description": "Enterprise software Market is also known as enterprise application software. It handles several operations of an organization and enhances the efficiency of businesses and management tasks…",
"keywords": "",
"snippet": "Enterprise Software Market Report Growth, Trends, COVID-19 Impact, and Forecast 2019–2028.\n\nEnterprise software Market is also known as enterprise application...",
"url": "https://medium.com/@shrutipathak2602/enterprise-software-market-report-growth-trends-covid-19-impact-and-forecast-2019-2028-2b23e1e50ac4",
"image_url": "https://miro.medium.com/1*m-R_BkNf1Qjr1YbyOIJY2w.png",
"language": "en",
"published_at": "2023-01-27T13:15:14.000000Z",
"source": "medium.com",
"relevance_score": null,
"entities": [
{
"symbol": "CRM.BA",
"name": "salesforce.com, inc.",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Technology",
"match_score": 20.304081,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Enterprise Software Market Key Players\n\nThe key competitors of this market include SAP SE, IBM Corporation, Oracle Corporation, Epicor Software Corporation, <em>Salesforce.com</em>, <em>Inc</em>., IFS, Infor, QAD Inc., Microsoft Corporation, and Hewlett-Packard.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SAP.BA",
"name": "SAP SE",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Technology",
"match_score": 15.762926,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Enterprise Software Market Key Players\n\nThe key competitors of this market include <em>SAP</em> <em>SE</em>, IBM Corporation, Oracle Corporation, Epicor Software Corporation, Salesforce.com, Inc., IFS, Infor, QAD Inc., Microsoft Corporation, and Hewlett-Packard.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ORCL.BA",
"name": "Oracle Corporation",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "Technology",
"match_score": 10.991435,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Enterprise Software Market Key Players\n\nThe key competitors of this market include SAP SE, IBM Corporation, <em>Oracle</em> <em>Corporation</em>, Epicor Software Corporation, Salesforce.com, Inc., IFS, Infor, QAD Inc., Microsoft Corporation, and Hewlett-Packard.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CRMD.BA",
"name": "SALESFORCE.COM INC",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 20.30409,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Enterprise Software Market Key Players\n\nThe key competitors of this market include SAP SE, IBM Corporation, Oracle Corporation, Epicor Software Corporation, <em>Salesforce.com</em>, <em>Inc</em>., IFS, Infor, QAD Inc., Microsoft Corporation, and Hewlett-Packard.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SAPD.BA",
"name": "SAP SE",
"exchange": "BCBA",
"exchange_long": "Buenos Aires Stock Exchange",
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 15.762938,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Enterprise Software Market Key Players\n\nThe key competitors of this market include <em>SAP</em> <em>SE</em>, IBM Corporation, Oracle Corporation, Epicor Software Corporation, Salesforce.com, Inc., IFS, Infor, QAD Inc., Microsoft Corporation, and Hewlett-Packard.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "ar",
"total_documents": 1140,
"sentiment_avg": 0.29018115432862474
}
]
}
Other details
Exchanges included in this country
- BCBA
- 444